晨光生物(300138.SZ)业绩快报:2025年净利润3.64亿元 同比增长286.65%

Core Insights - The company reported a significant increase in revenue and profits for the fiscal year 2025, with total revenue reaching 6.564 billion yuan, and operating profit and total profit growing by 313.92% and 311.82% respectively [1] - The net profit attributable to shareholders was 364 million yuan, marking a year-on-year increase of 286.65%, while the net profit after deducting non-recurring gains and losses and basic earnings per share saw increases of 595.83% and 320.30% respectively [1] Revenue and Profit Drivers - The growth in revenue and gross profit was primarily driven by the plant extraction business, while the cottonseed business experienced a decrease in trade volume but turned profitable due to a recovery in market conditions [1] - The company’s main product, chili red, achieved sales of 12,000 tons, a year-on-year increase of approximately 27%, and chili extract sales reached 2,900 tons, up about 65%, both hitting historical highs [2] - The customized product segment for chili red saw sales of over 2,200 tons, a 76% increase, while customized chili extract products increased by 171% with sales of over 450 tons [2] Additional Business Highlights - The stevia sugar business achieved a historical high in sales revenue of 280 million yuan through continuous product system improvement and customer structure optimization [2] - The spice product segment, particularly the core product of Sichuan pepper oil resin, saw significant revenue and profit growth, while milk thistle extract sales reached over 700 tons, a 66% increase [2] - The subsidiary Xinjiang Chenguang Protein successfully processed nearly 1 million tons of cottonseed, generating approximately 2.9 billion yuan in revenue and turning profitable through optimized internal management [2]

CCGB-晨光生物(300138.SZ)业绩快报:2025年净利润3.64亿元 同比增长286.65% - Reportify